| Literature DB >> 21483709 |
Fahima Chowdhury1, Mohammad Arif Rahman, Yasmin A Begum, Ashraful I Khan, Abu S G Faruque, Nirod Chandra Saha, Nabilah Ibnat Baby, M A Malek, Anisha Rajeev Kumar, Ann-Mari Svennerholm, Mark Pietroni, Alejandro Cravioto, Firdausi Qadri.
Abstract
BACKGROUND: In Bangladesh, increases in cholera epidemics are being documented with a greater incidence and severity. The aim of this prospective study was to identify the prevalence and importance of V. cholerae O1 and enterotoxigenic Escherichia coli (ETEC) as causal agents of severe diarrhea in a high diarrhea prone urban area in Dhaka city.Entities:
Mesh:
Year: 2011 PMID: 21483709 PMCID: PMC3071362 DOI: 10.1371/journal.pntd.0000999
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Demographic and clinical characteristics of patients from Mirpur between March 2008 and February 2010.
| Socio Demographic Features | Patients N = 31,588 (%) |
| Median age (years) | 18 |
| <1 years | 3329 (10) |
| 1 to 5 years | 8088 (26) |
| 6 to 17 years | 3386 (11) |
| ≥18 years | 16785 (53) |
| Male | 17114 (54) |
| Monthly income ≤10,000 taka | 24330 (77) |
| Treatment of drinking water | 21102 (67) |
|
| |
| Fever (>37.7°C) | 1100 (4) |
| Diarrhea for >4 days | 767 (2) |
| Watery stool | 30348 (96) |
| Bloody stool | 469 (2) |
| Abdominal pain | 18269 (58) |
| Vomiting prior to admission | 25001(79) |
| Severe dehydration on presentation | 12877 (41) |
| Use of ORS before arrival | 28994 (92) |
| Use of I.V before arrival | 1311(4) |
| Use of medication before arrival | 16436(52) |
| Intravenous rehydration | 12403 (39) |
| ORS used | 13554 (43) |
Figure 1Seasonality of cholera and ETEC diarrheal patients.
Figure 2Cholera hospitalization rate (ICDDR, B, Dhaka hospital) from Mirpur area.
Figure 3Cholera and ETEC hospitalization rate among the patients of different age group coming from Mirpur area.
Clinical features of cholera and ETEC diarrheal patients during study period from Mirpur.
| CholeraN = 2647 (%) | ETEC diarrheaN = 1248 (%) | Odds ratio(95% CI) |
| |
| Median age (yr) | 20 | 18 | ||
| <1 (yr) | 101(4) | 130 (11) | 0.34 (0.26–0.45) | <0.001*** |
| 1 to 5 (yr) | 495(19) | 377 (30) | 0.53 (0.45–0.62) | <0.001*** |
| 6 to 17 (yr) | 512(19) | 116 (9) | 2.34 (1.88–2.92) | <0.001*** |
| ≥18 (yr) | 1539(58) | 625 (50) | 1.38 (1.21–1.59) | <0.001*** |
| Male | 1395 (53) | 676 (54) | 0.94(0.82–1.08) | 0.39 |
| Fever (≥37.8°C) | 38 (1) | 47 (4) | 0.37 (0.24–0.59) | <0.001*** |
| Diarrhea for >4 days | 99 (4) | 62 (5) | 0.74 (0.53–1.04) | 0.07 |
| Watery stool | 2617 (99) | 1205 (97) | 3.11 (1.90–5.12) | <0.001*** |
| Bloody stool | 10 (>1) | 11 (1) | 0.43 (0.17–1.08) | 0.04 |
| Abdominal pain | 1508 (57) | 750 (60) | 0.88 (0.76–1.01) | 0.07 |
| Vomiting >10 times prior to admission | 520 (20) | 134 (11) | 2.03 (1.65–2.50) | <0.001*** |
| Severe dehydration on presentation | 1848 (70) | 475 (38) | 3.76 (3.26–4.35) | <0.001*** |
| ORS before arrival | 2419 (91) | 1158 (93) | 0.82 (0.63–1.07) | 0.14 |
| I.V. before arrival | 133 (5) | 33 (3) | 1.95 (1.30–2.93) | <0.001*** |
| Medication before arrival | 1237 (47) | 603 (48) | 0.94 (0.82–1.08) | 0.36 |
| Intravenous rehydration | 1714 (65) | 468 (37) | 3.06 (2.66–3.53) | <0.001*** |
| Monthly income ≤10,000 taka | 2242 (85) | 981 (79) | 1.51 (1.26–1.80) | <0.001*** |
| Treatment of drinking water | 1589 (60) | 835 (67) | 0.74 (0.64–0.86) | <0.001*** |
Confidence intervals (CI) and P values were derived from χ2 (chi-square) tests.
*denotes statistically significance.
Expression pattern of colonization factors for ETEC toxin type (March 2008 and February 2010).
| Colonization factors (CFs) | CFs positive ETEC isolatesN = 584(47% of total ETEC ) | CFs positive LT Producing ETEC isolatesN = 203 | CFs positive ST Producing ETEC isolatesN = 142 | CFs positive LT/ST Producing ETEC isolatesN = 239 |
| CS5+CS6 | 86 (15) | 3 | 11 | 72 |
| CS7 | 76 (13) | 74 | 0 | 2 |
| CS14 | 75 (13) | 8 | 4 | 63 |
| CS17 | 74 (13) | 66 | 0 | 8 |
| CS6 | 74 (13) | 22 | 40 | 12 |
| CS21 | 70 (12) | 7 | 33 | 30 |
| CFA/1 | 55 (9) | 3 | 30 | 22 |
| CS4+CS6 | 26 (5) | 3 | 13 | 10 |
| CS2+CS3 | 22 (4) | 8 | 4 | 10 |
| CS4 | 10 (2) | 0 | 3 | 7 |
| CS12 | 7 (1) | 4 | 1 | 2 |
| CS8 | 4 (>1) | 3 | 0 | 1 |
| CS1+CS3 | 3 (>1) | 1 | 2 | 0 |
| CS3 | 2 (>1) | 1 | 1 | 0 |
*With or without other CFs.